0000000001260651

AUTHOR

T Liu

showing 5 related works from this author

The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells

2013

In this study, we demonstrate that constitutive activation of Raf-1 oncogenic signaling induces stabilization and accumulation of Aurora-A mitotic kinase that ultimately drives the transition from an epithelial to a highly invasive mesenchymal phenotype in estrogen receptor α-positive (ERα(+)) breast cancer cells. The transition from an epithelial- to a mesenchymal-like phenotype was characterized by reduced expression of ERα, HER-2/Neu overexpression and loss of CD24 surface receptor (CD24(-/low)). Importantly, expression of key epithelial-to-mesenchymal transition (EMT) markers and upregulation of the stemness gene SOX2 was linked to acquisition of stem cell-like properties such as the ab…

Smad5 ProteinCancer ResearchEpithelial-Mesenchymal TransitionMAP Kinase Signaling SystemReceptor ErbB-2Active Transport Cell NucleusEstrogen receptorMice NudeBreast NeoplasmsBiologyArticleMicebreast cancerSOX2Cell MovementCell Line TumorGeneticsAnimalsHumansEpithelial–mesenchymal transitionKinase activityNeoplasm MetastasisPhosphorylationRNA Small InterferingMolecular BiologyAurora Kinase Ametastases mitosisSOXB1 Transcription FactorsEstrogen Receptor alphaCD24 AntigenXenograft Model Antitumor AssaysstemneGene Expression Regulation NeoplasticProto-Oncogene Proteins c-rafSettore BIO/18 - GeneticaTumor progressionembryonic structuresCancer researchMCF-7 CellsNeoplastic Stem CellsProto-Oncogene Proteins c-rafFemaleRNA InterferenceSignal transductionEstrogen receptor alphaNeoplasm Transplantation
researchProduct

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

2021

This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models wer…

MaleCOVID-19 COVIDSURG COVIDSURG CANCEROutcome AssessmentIMPACTSettore MED/18 - CHIRURGIA GENERALEBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Surgery.surgeryCancer surgeryNeoplasms/classificationBIOMEDICINA I ZDRAVSTVO. Javno zdravstvo i zdravstvena zaštita.Surgical oncologyNeoplasmsAcute careCOVID-19 - epidemiologyOutcome Assessment Health CareMedicine and Health Sciences80 and overGlobal healthtimingProspective StudiesUK610 Medicine & healthProspective cohort studyCOVID-19/epidemiologyCOVIDAged 80 and overBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Oncology.BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Kirurgija.Hazard ratioArticlesMiddle AgedOncologyAdult; Aged; Aged 80 and over; Communicable Disease Control; COVID-19; Female; Humans; Male; Middle Aged; Neoplasms; Outcome Assessment Health Care; Proportional Hazards Models; Prospective Studies; SARS-CoV-2; Time-to-Treatment; Withholding Treatment/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingFemalecancer surgeryCovid-19Life Sciences & BiomedicineMENTAL-HEALTHmental healthCohort studyHumanAdultmedicine.medical_specialtydelay3122 CancersCOVID-19 - prevention and control610 Medicine & healthCOVIDSurg CollaborativeNOTime-to-TreatmentSDG 3 - Good Health and Well-beingLockdownmedicineHumanscancer1112 Oncology and CarcinogenesisOncology & CarcinogenesisElective surgeryLS7_4Proportional Hazards ModelsAgedScience & Technologybusiness.industrySARS-CoV-2Public healthGeneral surgeryBIOMEDICINE AND HEALTHCARE. Public Health and Health Care.COVID-193126 Surgery anesthesiology intensive care radiologyHealth CareCommunicable Disease Control/legislation & jurisprudenceProspective StudieWithholding TreatmentCOVID-19; delay; SARS-CoV-2; surgery; timing; cancer surgery;COVID-19 ; lockdowns ; cancer surgeryCommunicable Disease ControlBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Onkologija.Proportional Hazards ModelNeoplasmbusiness
researchProduct

Higgs boson studies at the Tevatron

2013

We combine searches by the CDF and D0 Collaborations for the standard model Higgs boson with mass in the range 90-200 GeV/c2 produced in the gluon-gluon fusion, WH, ZH, tt̄H, and vector boson fusion processes, and decaying in the H→bb̄, H→W+W-, H→ZZ, H→τ+τ-, and H→γγ modes. The data correspond to integrated luminosities of up to 10 fb-1 and were collected at the Fermilab Tevatron in pp̄ collisions at √s=1.96 TeV. The searches are also interpreted in the context of fermiophobic and fourth generation models. We observe a significant excess of events in the mass range between 115 and 140 GeV/c2. The local significance corresponds to 3.0 standard deviations at mH=125 GeV/c2, consistent with the…

FERMILAB TEVATRON COLLIDERNuclear and High Energy PhysicsParticle physicsproton antiproton collisions; FERMILAB TEVATRON COLLIDER; Standard Model Higgs boson; BROKEN SYMMETRIESSTANDARD MODELP(P)OVER-BAR COLLISIONSTevatronFOS: Physical sciencesContext (language use)ATLAS DETECTORddc:500.2Standard Model Higgs boson7. Clean energy01 natural sciencesStandard ModelVector bosonHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)SEARCH0103 physical sciencesBibliography[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]BROKEN SYMMETRIESFermilab010306 general physicsPhysicsHIGGS BOSONB-JET IDENTIFICATIONLarge Hadron ColliderPP COLLISIONS010308 nuclear & particles physics4. EducationHigh Energy Physics::PhenomenologyROOT-S=1.96 TEVPARTON DISTRIBUTIONSExperimental High Energy PhysicsHiggs bosonproton antiproton collisionsComputingMethodologies_DOCUMENTANDTEXTPROCESSINGSYMMETRIESCDFB-JET IDENTIFICATION; STANDARD MODEL; ATLAS DETECTOR; PP COLLISIONS; P(P)OVER-BAR COLLISIONS; PARTON DISTRIBUTIONS; ROOT-S=1.96 TEV; SEARCH; LHC; SYMMETRIESHigh Energy Physics::ExperimentLHC
researchProduct

Performance of the ATLAS detector using first collision data

2010

More than half a million minimum-bias events of LHC collision data were collected by the ATLAS experiment in December 2009 at centre-of-mass energies of 0.9 TeV and 2.36 TeV. This paper reports on studies of the initial performance of the ATLAS detector from these data. Comparisons between data and Monte Carlo predictions are shown for distributions of several track- and calorimeter-based quantities. The good performance of the ATLAS detector in these first data gives confidence for successful running at higher energies.

Nuclear and High Energy PhysicsParticle physicsAtlas detectorPhysics::Instrumentation and DetectorsMonte Carlo methodFOS: Physical sciencesddc:500.253001 natural sciences7. Clean energySettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)LHC ; ATLAS ; Minimum-bias ; 900 GeV ; 2.36 TeV ; PerformanceAtlas (anatomy)0103 physical sciencesmedicine[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]ddc:530High Energy PhysicsDetectors and Experimental Techniques010306 general physicsCiencias ExactasDetectors de radiacióPhysicsHadron-Hadron ScatteringLarge Hadron Collider010308 nuclear & particles physicsATLAS DetectorSettore FIS/01 - Fisica SperimentaleATLAS experimentFísicaATLASCollisionmedicine.anatomical_structureExperimental High Energy PhysicsComputingMethodologies_DOCUMENTANDTEXTPROCESSINGHigh Energy Physics::ExperimentLHCParticle Physics - Experiment
researchProduct

Combination of measurements of the top-quark pair production cross section from the Tevatron Collider

2014

We combine six measurements of the inclusive top-quark pair (tt̄) production cross section (σtt̄) from data collected with the CDF and D0 detectors at the Fermilab Tevatron with proton-antiproton collisions at s=1.96TeV. The data correspond to integrated luminosities of up to 8.8fb-1. We obtain a value of σtt̄=7.60±0.41pb for a top-quark mass of mt=172.5GeV. The contributions to the uncertainty are 0.20 pb from statistical sources, 0.29 pb from systematic sources, and 0.21 pb from the uncertainty on the integrated luminosity. The result is in good agreement with the standard model expectation of 7.35-0.33+0.28pb at next-to-next-to-leading order and next-to-next-to leading logarithms in pert…

Top quarkP(P)OVER-BAR COLLISIONSTevatron7. Clean energylaw.inventionPhysics Particles & FieldsHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)law[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]HADRON COLLIDERSFERMILABFermilabNuclear ExperimentQuantum chromodynamicsPhysicsLarge Hadron ColliderPhysicsP(P)OVER-BAR COLLISIONS; ROOT-S=1.96 TEV; PARTON DISTRIBUTIONS; HADRON COLLIDERS; LEADING ORDER; T(T)OVER-BAR; DETECTOR; LHC; QCD; FERMILABPerturbative QCD3. Good healthROOT-S=1.96 TEVPhysical SciencesComputingMethodologies_DOCUMENTANDTEXTPROCESSINGLHCT(T)OVER-BARParticle physicsNuclear and High Energy PhysicsFOS: Physical sciencesAstrophysics::Cosmology and Extragalactic AstrophysicsAstronomy & AstrophysicsMASSNuclear physicsSEARCHColliderParticle PhysicsDETECTORAstrophysics::Galaxy AstrophysicsScience & Technologyhep-exLEADING ORDERHigh Energy Physics::PhenomenologyTop quarkQCDP(P)OVER-BAR COLLISIONS; T(T)OVER-BAR; DETECTOR; SEARCH; MASSPair productionPARTON DISTRIBUTIONSExperimental High Energy PhysicsCollider PhysicsCDFHigh Energy Physics::ExperimentParticle Physics; Collider Physics; Top quark
researchProduct